Myria Biosciences AG
Irene Wuethrich is a co-founder at Myria Biosciences since December 2021 and previously co-founded SpheroBiotics, serving from August 2018 to November 2021. Irene's extensive academic background includes positions as a Pioneer Fellow and postdoctoral researcher at ETH Zurich from April 2014 to September 2021. Earlier experience includes co-founding Something GUD, Inc. from 2012 to 2015, and completing a PhD at the Whitehead Institute for Biomedical Research at MIT from April 2008 to February 2014. Educational qualifications include a Master of Science in Biotechnology from ESBS (2004-2007) and a Vordiplom in Biology from the University of Bern (2002-2004).
This person is not in the org chart
This person is not in any teams
Myria Biosciences AG
Myria Biosciences pioneers GEMMS (Genetically Engineered Modular Molecule Scaffolds), a new class of therapeutic molecules that combines the most important features of small molecules and biologics, the two work horses of the pharmaceutical industry, into one. Myria’s platform uses computational data mining, synthetic biology and high-throughput experimentation to design, produce and test millions of novel molecules, and provides innovative drug candidates for diseases where other drugs have failed to deliver.